Ahmedabad, India

Balvir Singh

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Sanand, IN (2022)
  • Ahmedabad, IN (2018 - 2023)

Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Balvir Singh: Innovator in Pharmaceutical Composition

Introduction

Balvir Singh, a distinguished inventor based in Ahmedabad, India, has made significant contributions to the pharmaceutical field with his innovative work. With three patents to his name, he is recognized for developing formulations that enhance medication effectiveness and patient compliance.

Latest Patents

Among his latest innovations, Balvir has developed an extended release pharmaceutical composition of Clozapine. This innovative formulation features Clozapine, along with a seal coating, an acidic coating, and an extended release coating. Designed for once-a-day dosing, this solid oral formulation is engineered to provide a therapeutically effective amount of Clozapine over an extended period, ensuring improved management for patients requiring this medication.

Career Highlights

Balvir Singh works at Intas Pharmaceuticals Limited, a leading player in the pharmaceutical industry. His work focuses on advancing drug delivery systems, particularly in creating formulations that improve patient adherence to treatment regimens.

Collaborations

During his career, Balvir has collaborated with esteemed colleagues such as Ashish Sehgal and Mayank Saxena. This teamwork has fostered a dynamic environment for innovation and has contributed to the successful patenting of their collective research efforts.

Conclusion

With a commitment to innovation and excellence, Balvir Singh continues to pave the way for advancements in pharmaceutical compositions. His patents not only enhance therapeutic efficacy but also demonstrate the importance of continuous research and development in medicine, ensuring better outcomes for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…